|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 29/00 | |
| A61K 9/107 | |||
| A61K 47/12 | |||
| A61K 47/14 |
| (11) | Patento numeris | 2613809 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11760887.7 |
| Europos patento paraiškos padavimo data | 2011-09-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-07-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/001567 |
| Data | 2011-09-12 |
| (87) | Numeris | WO 2012/033538 |
| Data | 2012-03-15 |
| (30) | Numeris | Data | Šalis |
| 923257 | 2010-09-10 | US |
| (72) |
DRISCOLL, David F., US
|
| (73) |
Stable Solutions LLC,
551 Mills Way, Goleta, California 93117,
US
|
| (54) | METHOD OF MITIGATING ADVERSE DRUG EVENTS USING OMEGA-3 FATTY ACIDS AS A PARENTERAL THERAPEUTIC DRUG VEHICLE |
| METHOD OF MITIGATING ADVERSE DRUG EVENTS USING OMEGA-3 FATTY ACIDS AS A PARENTERAL THERAPEUTIC DRUG VEHICLE |